Amphastar Pharmaceuticals, Inc. (AMPH)
19.34
-1.10
(-5.38%)
USD |
NASDAQ |
Mar 06, 16:00
19.24
-0.10
(-0.52%)
After-Hours: 20:00
Amphastar Pharmaceuticals Shareholders Equity (Quarterly) : 788.80M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 26.54B |
| Organon & Co. | 752.00M |
| Catalyst Pharmaceuticals, Inc. | 954.27M |
| Johnson & Johnson | 81.54B |
| Pfizer Inc. | 86.48B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.678B |
| Total Liabilities (Quarterly) | 888.89M |
| Debt to Equity Ratio | 0.8316 |
| Current Ratio | 4.021 |
| Net Debt Paydown Yield | -0.43% |